Loading...
A "Knife Fight" with the FDA: The Trump White House's Relentless Attacks on FDA's Coronavirus Response
House Committee on Oversight and Reform Select Subcommittee on the Coronavirus Crisis
House Committee on Oversight and Reform
Select Subcommittee on the Coronavirus Crisis
Abstract
This report from the Select Subcommittee on the Coronavirus Crisis of the House Committee on Oversight and Reform is the second installment of findings from its investigation into the federal government's coronavirus pandemic response. The report focuses on three instances where Trump White House officials exerted coordinated pressure on the Food and Drug Administration (FDA) to align with political objectives. The report states the instances involve efforts to reauthorize hydroxychloroquine despite its ineffectiveness and potential danger, influence FDA's messaging on convalescent plasma before the 2020 Republican National Convention, and delay FDA guidance on coronavirus vaccine authorizations for political reasons.
Date
2022-08-24
Document Type
House Staff Report
Serial Number
Document Length
69 pages
Congress
117
Relation
DOI
Keywords
Staff Reports
PAP Major Code
3: Health
PAP Minor Code
331: Public Health and Disease Prevention